Litecoin earned the ire of XRP holders after the project’s official account on X tweeted in mockery of Ripple XRP and its CEO, Brad Garlinghouse. The post, which started as a fun fact about comets, quickly escalated due to the comparison with XRP. According to the post, the idea that XRP would grow substantially in […]Litecoin earned the ire of XRP holders after the project’s official account on X tweeted in mockery of Ripple XRP and its CEO, Brad Garlinghouse. The post, which started as a fun fact about comets, quickly escalated due to the comparison with XRP. According to the post, the idea that XRP would grow substantially in […]

Ripple community unloads on Litecoin over 'rotten eggs' comment

Litecoin earned the ire of XRP holders after the project’s official account on X tweeted in mockery of Ripple XRP and its CEO, Brad Garlinghouse. The post, which started as a fun fact about comets, quickly escalated due to the comparison with XRP.

According to the post, the idea that XRP would grow substantially in value because it would become an on-off ramp for traditional institutions in the future is nothing but a smelly illusion.

The opening part of the post reads:

It went further to lampoon the idea that Ripple will replace SWIFT as the dominant banking rail, sarcastically referring to speculations about other factors that could drive XRP’s future growth, including the limited number of tokens and Ripple’s CEO’s close association with Donald Trump.

XRP community hit back at Litecoin

Whatever Litecoin’s intention might have been, the post has been met with massive negative reaction, mostly from XRP community members. Some focused their criticisms on Litecoin itself, noting that the founder of Litecoin, Charlie Lee, sold the token back in December 2017, noting that this as a sign of a lack of conviction.

Others focused on how Litecoin’s value has declined over the years. LTC peaked at around $412.96 back in 2021 but now trades at $109.61, representing over 73% decline in value.

Crypto attorney Bill Morgan said:

Meanwhile, others warned that Ripple could file a defamation or trade libel lawsuit against Litecoin, given that LTC is a competitor for XRP. Many also noted that Litecoin itself has faced criticisms from the broader crypto community in the past, but it is now doing the same to other crypto assets.

However, the wave of criticisms has not stopped the Litecoin account handler and its supporters. The account also countered that Ripple founders sold the tokens while adding that it is not a competitor for XRP like XLM. The initial post has also generated significant engagement with over 700,000 views on X.

In the latest sign of doubling down, the Litecoin account observed how it has roasted other crypto projects with little pushback, but its criticism of XRP was enough to ignite a fire.

It posted:

Meanwhile, Litecoin supporters are backing the project, noting that it is nothing like XRP and does not serve a similar purpose.

XRP and LTC decline in the last 24 hours

Despite the strong animosity that the members of both camps have against each other on X, the two tokens have had a similar price performance in the past few months. According to CoinMarketCap, XRP and LTC are both down more than 1% 24 hours, while XRP saw a more significant drop in the week.

While their declines might be due to the broader crypto market performance, both tokens have also seen more than 20% gains in the last three months, indicating that they are on a resurgence.

LTC is up 23% while XRP gained 25%. XRP is also the clear leader for year-to-date gains with 19.28% even though Litecoin is up 4.30%.

KEY Difference Wire helps crypto brands break through and dominate headlines fast

Market Opportunity
Sport.Fun Logo
Sport.Fun Price(FUN)
$0.08185
$0.08185$0.08185
+309.25%
USD
Sport.Fun (FUN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23